{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:13:18Z","timestamp":1788401598876,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vaccine.2025.127960","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:54:35Z","timestamp":1763042075000},"page":"127960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Immunogenicity and safety of a SARS-CoV-2\u00a0N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants"],"prefix":"10.1016","volume":"69","author":[{"given":"Christina M.","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahnuma","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kandinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darby","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avika","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kogawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Chalkias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127960_bb0005","article-title":"COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European region (2022\u22122023): a test-negative case-control study from the EuroSAVE network","volume":"47","author":"Katz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.vaccine.2025.127960_bb0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-2600(24)00179-6","article-title":"Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European region from December, 2020, to march, 2023: a retrospective surveillance study","volume":"12","author":"Mesle","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2025.127960_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126966","article-title":"Durability of COVID-19 vaccine and infection induced immunity: a systematic review and meta-regression analysis","volume":"54","author":"Moore","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127960_bb0020","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1473-3099(22)00409-1","article-title":"Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant","volume":"22","author":"Higdon","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127960_bb0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.127960_bb0030","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/14760584.2024.2397026","article-title":"A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children","volume":"23","author":"Priddy","year":"2024","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2025.127960_bb0035","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/evolut\/qpae041","article-title":"Endemic does not mean constant as SARS-CoV-2 continues to evolve","volume":"78","author":"Otto","year":"2024","journal-title":"Evolution"},{"key":"10.1016\/j.vaccine.2025.127960_bb0040","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1093\/infdis\/jiaf022","article-title":"Safety and immunogenicity of SARS-CoV-2 spike receptor-binding domain and N-terminal domain mRNA vaccine","volume":"231","author":"Chalkias","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127960_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106256","article-title":"Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants","volume":"26","author":"Montgomerie","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2025.127960_bb0050","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/vaccines9091033","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","volume":"9","author":"Uddin","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127960_bb0055","doi-asserted-by":"crossref","first-page":"2190690","DOI":"10.1080\/21645515.2023.2190690","article-title":"Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults","volume":"19","author":"Yassini","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.127960_bb0060","series-title":"Food and Drug Administration (FDA). mNEXSPIKE","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127960_bb0065","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S1473-3099(25)00236-1","article-title":"Efficacy, immunogenicity, and safety of a next-generation mRNA-1283 COVID-19 vaccine compared with the mRNA-1273 vaccine (NextCOVE): results from a phase 3, randomised, observer-blind, active-controlled trial","volume":"25","author":"Chalkias","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127960_bb0070","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3201\/eid2909.230365","article-title":"Infection-induced SARS-CoV-2 seroprevalence among blood donors, Japan, 2022","volume":"29","author":"Kinoshita","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127960_bb0075","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.3201\/eid3006.231454","article-title":"Infection- and vaccine-induced SARS-CoV-2 seroprevalence, Japan, 2023","volume":"30","author":"Kinoshita","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127960_bb0080","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3201\/eid3105.250021","article-title":"Detection of SARS-CoV-2 reinfections using nucleocapsid antibody boosting","volume":"31","author":"Grebe","year":"2025","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127960_bb0085","unstructured":"Department of Health and Human Services (DHHS); Food and Drug Administration; Center for Biologics Evaluation and Research (US). Guidance for industry: Toxicity grading scale for healthy adult and adolescent volunteers enrolled in preventive vaccine clinical trials; 2007. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/toxicity-grading-scale-healthy-adult-and-adolescent-volunteers-enrolled-preventive-vaccine-clinical."},{"key":"10.1016\/j.vaccine.2025.127960_bb0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s40121-025-01160-z","article-title":"Evaluating the impact of age and comorbidities on COVID-19 outcomes and healthcare costs: a comparative analysis of immunocompromised and general populations in the United States (EON-US)","volume":"14","author":"Fang","year":"2025","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2025.127960_bb0095","doi-asserted-by":"crossref","first-page":"1144824","DOI":"10.3389\/fphar.2023.1144824","article-title":"COVID-19 vaccination effectiveness and safety in vulnerable populations: a meta-analysis of 33 observational studies","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2025.127960_bb0100","first-page":"1","article-title":"Indirect comparison of the relative vaccine effectiveness of mRNA-1283 vs. BNT162b2 vaccines against symptomatic COVID-19 among US adults","author":"Beck","year":"2025","journal-title":"Curr Med Res Opin"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25012587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:02:33Z","timestamp":1766073753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25012587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"alternative-id":["S0264410X25012587"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127960","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of a SARS-CoV-2\u00a0N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127960"}}